Sustainability to drive Pregis product development in Europe

Published: 10-Dec-2010
Packaging Finance

To focus on environmentally friendly products in 2011

The new president of Pregis’ European protective packaging business says the firm will focus on sustainable products in new product developments for 2011.

Kevin Baudhuin has been president of Pregis’ North American protective packaging business since 2007.

He has now been promoted to president of global protective packaging where he will lead Pregis Protective Packaging Europe.

Baudhuin said the firm aimed to create a broad environmentally friendly product portfolio suitable for a number of markets, including medical and pharmaceutical products.

The company already offers its Superlite poly Mailer and EP-Flex Renew biodegradable film products.

‘We recognise that any sustainable solution must still meet other key requirements such as high performance and cost-effectiveness and we will therefore ensure that our products continue to satisfy all these criteria,’ said Baudhuin.

He added that the firm’s growth strategy would focus on three main areas of sustainability, innovation and customer partnerships.

See more

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

Read more
The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance

Trending Articles

  1. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  2. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  3. Applied Biopharm Consulting secures IP grant to protect AI-driven viral capsid engineering innovations Irish biotech consultancy Applied Biopharm Consulting has received an IP Start Grant from Enterprise Ireland to develop a formal patent strategy around its AI-powered computational platform for engineered adeno-associated virus vector design
  4. CordenPharma Colorado expands peptide development capacity with lease of new lab Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    kyron.bio partners with Servier to advance precision glycosylation in antibody therapeutics The parternship will allow kyron.bio to apply its precision glycoengineering platform to antibody development. Speaking exclusively with Manufacturing Chemist, CEO of kyron.bio, Dr Emilia McLaughlin, explains the importance of the new deal

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance
Packaging

Pregis launches high speed bagger with predictive maintenance

The unit features an intuitive user interface and thermal printing technology, which prints bar codes, graphics and alphanumeric fonts directly onto the package
Packaging

Pregis adds bagging systems to protective packaging portfolio

The protective packaging company has acquired Sharp Packaging Systems and its flexible bagging systems capability
Packaging

Pregis acquires UK-based protective packaging company Easypack

Will expand its North American portfolio to include paper void fill, cushioning and block/brace solutions
Manufacturing

Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters

Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Manufacturing

SGD Pharma partners with Prince Sterilisation Services for pharmaceutical glass packaging

The pair have already launched the My Sterinity Nasal platform, a new, versatile sterile vial range within SGD Pharma's My Sterinity RTU platform, using the company's U-Save Type I vials, which are designed to support the growing segment of high-value nasal drug delivery
Subscribe now